# Chemokine CXCL12/CXCR4 system and synthetic cathinones

> **NIH NIH R01** · TEMPLE UNIV OF THE COMMONWEALTH · 2020 · $158,500

## Abstract

Human death in persons infected with SARS-CoV-2 (the virus responsible for the covid-19
pandemic) is caused by barriers dysfunction (i.e. in the pulmonary system). Angiotensin-
converting enzyme 2 (ACE2) has been identified as a functional receptor of SARS-CoV-2,
similarly to other coronaviruses. Surface expression of ACE2 protein was found on lung
alveolar epithelial cells and enterocytes of the small intestine. In brain, ACE2 is expressed on
endothelial cells, a major component of blood-brain barrier (BBB). We propose to perform a
series of studies to assess the impact of SARS-CoV-2 spike protein on BBB function in the
presence of cocaine as an extension of our funded research on psychostimulants and the
CXCL12/CXCR4 chemokine system. First, a comprehensive series of experiments on the
impact of SARS-CoV-2 spike protein in the presence and absence of cocaine on brain
microvascular endothelial cells will be performed in vitro to inform on the cellular and molecular
mechanism involved in altered BBB function. Included in the analysis will be measurements of
cytosolic Ca2+ levels, mitochondrial reactive oxygen species, tight junctions and cytoskeletal
proteins. Second, integrated fluorescence microscopy will be used to visualize and quantify
changes in BBB permeability in real time in awake rats after exposure to SARS-CoV-2 spike
protein. The impact of acute and chronic administration of cocaine on BBB function in the
setting of SARS-CoV-2 spike protein will be determined. Finally, brain regions from rats
exposed to cocaine and the spike protein will be examined for levels of pro-inflammatory
cytokines and chemokines. Taken together, this series of experiments will provide novel
information about the effect of the spike protein on BBB function and neuroinflammation, and its
potential interactions with cocaine. We hypothesize that chronic cocaine exposure will
exacerbate the negative impact of SARS-CoV-2 spike protein on BBB integrity and increase
pro-inflammatory mediators in the CNS. These studies will provide the necessary groundwork to
embark on a larger study of the impact of SARS-CoV-2 on cocaine behaviors and toxicities.

## Key facts

- **NIH application ID:** 10187189
- **Project number:** 3R01DA045499-03S1
- **Recipient organization:** TEMPLE UNIV OF THE COMMONWEALTH
- **Principal Investigator:** SCOTT M. RAWLS
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $158,500
- **Award type:** 3
- **Project period:** 2018-07-01 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10187189

## Citation

> US National Institutes of Health, RePORTER application 10187189, Chemokine CXCL12/CXCR4 system and synthetic cathinones (3R01DA045499-03S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10187189. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*